Birchview Capital »

ImmunoGen shares owned by Birchview Capital

Quarter-by-quarter ownership of ImmunoGen shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Birchview Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0M 190k 15.87
2023-06-30 $3.6M 190k 18.87
2023-03-31 $576k 150k 3.84
2022-12-31 $744k 150k 4.96
2022-09-30 $717k 150k 4.78
2022-06-30 $675k 150k 4.50
2022-03-31 $904k 190k 4.76
2021-12-31 $1.4M 190k 7.42
2021-09-30 $1.1M 190k 5.67
2021-06-30 $1.3M 190k 6.59
2021-03-31 $1.5M 190k 8.10
2020-12-31 $1.2M 190k 6.45
2020-09-30 $684k 190k 3.60
2020-06-30 $874k 190k 4.60
2020-03-31 $648k 190k 3.41
2019-12-31 $920k 180k 5.11
2019-09-30 $436k 180k 2.42
2019-06-30 $391k 180k 2.17
2019-03-31 $244k 90k 2.71
2018-12-31 $106k 22k 4.82